Oxidative stress, NOx/l-arginine ratio and glutathione/glutathione S-transferase ratio as predictors of ‘sterile inflammation’ in patients with alcoholic cirrhosis and hepatorenal syndrome type II

References

• Arroyo V, Fernandez J, Ginès P. Pathogenesis and treatment of hepatorenal syndrome. Semin Liver Dis. 2008;28:81–95.
   PubMed Web of Science ®Google Scholar
• Bolognesi M, Pascoli M, Verardo A, et al. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis. World J Gastroenterol. 2014;20:2555–2563.
   PubMed Web of Science ®Google Scholar
• Salerno F, Gerbes A, Ginès P, et al. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56:1310–1318.
   PubMed Web of Science ®Google Scholar
• Blendis L, Wong F. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome. Clin Med (Lond). 2003;3: 154–159.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Guevara M, Ginès P. Hepatorenal syndrome in cirrhosis: pathogenesis and treatment. Gastroenterology. 2002;122:1658–1676.
   PubMed Web of Science ®Google Scholar
• Rao K, Seth A, Sheth P. Recent advances in alcoholic liver disease: role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol. 2004;286:G881–G884.
   PubMed Web of Science ®Google Scholar
• Cederbaum I, Lu Y, Wu D. Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol. 2009;83: 519–548.
   PubMed Web of Science ®Google Scholar
• Niki E. Lipid peroxidation products as oxidative stress biomarkers. Biofactors. 2008;34:171–180.
   PubMed Web of Science ®Google Scholar
• Chen G, Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10: 826–837.
   PubMed Web of Science ®Google Scholar
• Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010;2010:672395.
   PubMed Web of Science ®Google Scholar
• Pizzimenti S, Toaldo C, Pettazzoni P, et al. The “Two-Faced” effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer. Cancers. 2010;2:338–363.
   PubMedGoogle Scholar
• Albano E. New concepts in the pathogenesis of alcoholic liver disease. Expert Rev Gastroenterol Hepatol. 2008;2:749–759.
   PubMedGoogle Scholar
• Ničković V, Nikolić J, Kocić G, et al. Complications of alcoholic liver disease and diagnostic markers. Acta Medica Medianae. 2011;50:55–61.
   Google Scholar
• Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med. 1999;27:916–921.
   PubMed Web of Science ®Google Scholar
• Lushchak VI. Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids. 2012;2012:736837.
   PubMedGoogle Scholar
• Zuwała-Jagiełło J, Pazgan-Simon M, Simon K, et al. Advanced oxidation protein products and inflammatory markers in liver cirrhosis: a comparison between alcohol-related and HCV-related cirrhosis. Acta Biochemica Polonica. 2011;58:59–66.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Nguyen Khoa T, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol. 1998;161:2524–2532.
   PubMed Web of Science ®Google Scholar
• Nicković V, Nikolić J, Djindjić N, et al. Diagnostical significance of dimethylarginine in the development of hepatorenal syndrome in patients with alcoholic liver cirrhosis. Vojnosanitetski Pregled. 2012;69:686–691.
   PubMed Web of Science ®Google Scholar
• Angeli P, Merkel C. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. J Hepatol. 2008;48:S93–S103.
   PubMed Web of Science ®Google Scholar
• Shuo Hu L, George J, Wang J. Current concepts on the role of nitric oxide in portal hypertension. World J Gastroenterol. 2013;19:1707–1717.
   Web of Science ®Google Scholar
• Madan K, Mehta A. Management of renal failure and ascites in patients with cirrhosis. Int J Hepatol. 2011;2011:790232.
   PubMedGoogle Scholar
• Iwakiri Y, Groszmann J. Vascular endothelial dysfunction in cirrhosis. J Hepatol. 2007;46:927–934.
   PubMed Web of Science ®Google Scholar
• Ledwozyd A, Michalak B, Stepien A, et al. The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis. Clin Chim Acta.1986;155:275–284.
   PubMed Web of Science ®Google Scholar
• Sedlak J, Lindsay H. Estimation of total, protein-bound, and nonprotein sulfydryl groups in tissue with Ellman’s reagent. Anal Biochem. 1968;25:192–205.
   PubMed Web of Science ®Google Scholar
• Habig H, Pabst J, Jakoby B. Glutathione-S-transferases. J Biol Chem. 1974;249:7130–7134.
   PubMed Web of Science ®Google Scholar
• Đorđević V, Pavlović D. Methods for determination of NO and products of nitrosylation. In: Djordjevic V, editor. Biochemical markers of oxidative stress in experimental and clinical medicine. Niš: Medical Faculty Nis; 2006; p. 123.
   Google Scholar
• Nlemelä O, Parkkila S, Ylä-herttuala S, et al. Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol-induced liver disease issue. Hepatology. 2005;22:1208–1214.
   Google Scholar
• Vuppalanchi R, Juluri R, Bell LN, et al. Oxidative stress in chronic liver disease: relationship between peripheral and hepatic measurements. Am J Med Sci. 2011; 342:314–317.
   PubMed Web of Science ®Google Scholar
• Duryee J, Willis S, Freeman L, et al. Mechanisms of alcohol liver damage: aldehydes, scavenger receptors, and autoimmunity. Front Biosci. 2004;9:3145–3155.
   PubMed Web of Science ®Google Scholar
• McVicker B, Tuma D, Kharbanda K, et al. Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kupffer cells in the presence of apoptotic cells. Alcoholism Clin Exp Res. 2007;31:122–129.
   PubMed Web of Science ®Google Scholar
• Thiele M, Duryee J, Willis S, et al. Malondialdehyde-acetaldehyde (MAA) modified proteins induce proinflammatory and pro-fibrotic responses by liver endothelial cells. Comp Hepatol. 2004;3:1–25.
   PubMedGoogle Scholar
• Aleynik I, Leo A, Aleynik K, et al. Increased circulating products of lipid peroxidation in patients with alcoholic liver disease. Alcoholism Clin Exp Res. 2006;22: 192–196.
   Google Scholar
• Mortensen C, Andersen O, Krag A, et al. High-sensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis. Eur J Gastroenterol Hepatol. 2012;24:619–626.
   PubMed Web of Science ®Google Scholar
• Rouach H, Fataccioli V, Gentil M, et al. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology. 1997;25(2):351–355.
   PubMed Web of Science ®Google Scholar
• Alderton W, Cooper C, Knowles R. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357:593–615.
   PubMed Web of Science ®Google Scholar
• Ničković V, Kocić G, Bjelaković G, et al. Diagnostic significance of nitrates and nitrites and L-arginine, in development of hepatorenal syndrome in patients with end stage alcoholic liver cirrhosis. Ren Fail. 2013;35(5):633–639.
   PubMed Web of Science ®Google Scholar
• Grangé JD, Amiot X. Nitric oxide and renal function in cirrhotic patients with ascites: from physiopathology. Eur J Gastroenterol Hepatol. 2004;16:567–570.
   PubMed Web of Science ®Google Scholar
• Kirkham P. Oxidative stress and macrophage function: a failure to resolve the inflammatory response. Biochm Soc Trans. 2007;35:284–287.
   PubMed Web of Science ®Google Scholar
• Arteel E. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterol. 2000;124:778–790.
   Google Scholar
• Czezot H, Scibior D, Skrzycki M, et al. Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma. Acta Biochim Pol. 2006;53:237–242.
   PubMed Web of Science ®Google Scholar
• Fortune1 B, Cardenas A. Ascites, refractory ascites and hyponatremia in cirrhosis. Gastroenterol Rep. 2017;5: 104–112.
   Google Scholar
• Colle I, Durand F, Pessione F, et al. Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis. J Gastroenterol Hepatol. 2002;17:882–888.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Ginès P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology. 1996;23(1):164–176.
   PubMed Web of Science ®Google Scholar
• Barreto R, Fagundes C, Guevara M, et al. Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival. Hepatology. 2014;59:1505–1513.
   PubMed Web of Science ®Google Scholar
• Salerno F, Monti V. Hepatorenal syndrome type 1 and bacterial infection: a catastrophic association in patients with cirrhosis. Hepatology. 2014;59: 1239–1241.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Canaud B, Eckardt U, et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18: 1272–1280.
   PubMed Web of Science ®Google Scholar
• Marta R, Rosa N, Luís M, et al. Evaluation of oxidative stress biomarkers in patients with chronic renal failure: a case control study. BMC Res Notes. 2010;3:20.
   PubMedGoogle Scholar
• Fialova L, Malbohan I, Kalousova M, et al. Oxidative stress and inflammation in pregnancy. Scand J Clin Lab Invest. 2006;66:121–127.
   PubMed Web of Science ®Google Scholar
• Lu Y, Cederbaum I. CYP2E1 potentiation of LPS and TNFalpha-induced hepatotoxicity by mechanisms involving enhanced oxidative and nitrosative stress, activation of MAP kinases, and mitochondrial dysfunction. Genes Nutr. 2010;2:149–167.
   Google Scholar
• Woods A, Davies J. Fragmentation of extracellular matrix by hypochlorous acid. Biochem J. 2003;376: 219–227.
   PubMed Web of Science ®Google Scholar
• Branden V, Verelst R, Vamecq J, et al. Effect of vitamin E on antioxidant enzymes, lipid peroxidation products and glomerulosclerosis in the rat remnant kidney. Nephron. 1997;76:77–81.
   PubMed Web of Science ®Google Scholar
• Ferri C, Croce G, Cofini V, et al. C-reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis. Curr Pharm Des. 2007;13:1631–1645.
   PubMed Web of Science ®Google Scholar
• Memon A, Staprans I, Noor M, et al. Infection and inflammation induce LDL oxidation in vivo. Arterioscler Thromb Vasc Biol. 2000;20:1536–1542.
   PubMed Web of Science ®Google Scholar
• Hamilton T, Asatryan L, Nilsen T, et al. LDL protein nitration: implication for LDL protein unfolding. Arch Biochem Biophys. 2008;1:1–14.
   Google Scholar
• Islam N, O’Byrne D, Devaraj S, et al. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis. 2000;150:217–224.
   PubMed Web of Science ®Google Scholar
• Ottaviano G, Tang S, Handy E, et al. Regulation of the extracellular antioxidant selenoprotein plasma glutathione peroxidase (GPX-3) in mammalian cells. Mol Cell Biochem. 2009;327:111–126.
   PubMed Web of Science ®Google Scholar
• Cortes-Rojo C, Calderon-Cortes E, Clemente-Guerrero M, et al. Elucidation of the effects of lipoperoxidation on the mitochondrial electron transport chain using yeast mitochondria with manipulated fatty acid content. J Bioenerg Biomembr. 2009;41:15–28.
   PubMed Web of Science ®Google Scholar
• Granata S, Zaza G, Simone S, et al. Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics. 2009;10:388.
   PubMed Web of Science ®Google Scholar
• Galkina I, Dormeneva V, Bachschmid M, et al. Endothelium-leukocyte interactions under the influence of the superoxide-nitrogen monoxide system. Med Sci Monit. 2004;10:307–316.
   Web of Science ®Google Scholar
• Closs I, Basha Z, Habermeier A, et al. Interference of L-arginine analogues with L-arginine transport mediated by the y + carrier hCAT-2B. Nitric Oxide. 1997;1:65–73.
   PubMed Web of Science ®Google Scholar
• Tojo A, Welch J, Bremer V, et al. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney Int. 1997;52:1593–1601.
   PubMed Web of Science ®Google Scholar
• Ferraro B, Galli F, Frei B, et al. Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients. Kidney Int. 2003;6:2207–2211.
   Google Scholar
• Oberg P, McMenamin E, Lucas L, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004;65:1009–1016.
   PubMed Web of Science ®Google Scholar